MLYS SG&A Expense Growth
Mineralys Therapeutics Inc · SG&A Expense Growth
MLYS SG&A Expense Growth
Latest reported62.01%period ending
MLYS FY SG&A Growth (YoY) (0.00% → 62.01%)
Latest values, visible window
High-resolution chart · PNG
MLYS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 62.0141% | |
| 66.634% | |
| 173.3984% | |
| 116.3426% | |
| 354.3233% | |
| 0% |